Skip to content

Evaluation of immune function for patients with bile duct cancer before and after chemotherapy

Evaluation of immune function for patients with bile duct cancer before and after chemotherapy - Evaluation of immune function for patients with bile duct cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000009037
Enrollment
30
Registered
2012-10-10
Start date
2012-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct cancer

Interventions

None listed

Sponsors

Graduate School of Medicine, Yokohama City University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Bile duct cancer patients more than 20 year old who agreed to participate in this study

Exclusion criteria

Exclusion criteria: Bile duct cancer patients who did not agree to participate in this study

Design outcomes

Primary

MeasureTime frame
Measurement of T lymphocyte subset and lymphoproliferative capacity before and after chemotherapy

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026